04/28/2025
3:59 PM | Aptose Biosciences (Filer)
| Form DEF 14A | |
04/23/2025
5:04 AM | Aptose Biosciences (Filer)
| Form PRER14A | |
04/21/2025
4:28 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
4:08 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
04/03/2025
3:27 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
7:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
9:46 AM | Aptose Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2025
7:42 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
5:48 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G/A | |
03/24/2025
4:02 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
6:14 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for APTO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
03/20/2025
7:54 PM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
03/20/2025
7:54 PM | Aptose Biosciences (Issuer)
Hanmi Pharmaceutical Co., Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:12 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:26 PM | Aptose Biosciences (Subject)
Bleichroeder LP (Filed by)
| Form SCHEDULE 13G | |
02/13/2025
4:30 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
02/13/2025
4:14 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
3:42 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:41 PM | Aptose Biosciences (Filer)
| Form 424B5 | |
01/28/2025
3:31 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
4:21 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:01 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
6:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
5:57 PM | Aptose Biosciences (Filer)
| Form DEF 14A | |
12/27/2024
5:59 PM | Aptose Biosciences (Filer)
| Form DEFA14A | |
12/19/2024
3:10 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:03 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
12/12/2024
9:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
5:56 PM | Aptose Biosciences (Issuer)
Rice William G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:27 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B4 | |
11/22/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
11/20/2024
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
2:22 PM | Aptose Biosciences (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
10/31/2024
5:39 AM | Aptose Biosciences (Filer)
| Form S-1/A | |
Donald Trump is about to free crypto from its chains … (Ad) Sure enough, Bitcoin took off on the exact day Juan said it would.
It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .…
Now Juan believes it could hit $150,000 … or higher in 2025. There's another coin he thinks could do even better. |
10/04/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:15 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:22 PM | Aptose Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
8:43 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:00 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
10:43 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
07/05/2024
9:19 AM | Aptose Biosciences (Filer)
| Form PRE 14A | |
06/14/2024
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:35 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
9:32 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Aptose Biosciences (Filer)
| Form 424B5 | |
05/31/2024
7:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
10:47 AM | Aptose Biosciences (Filer)
| Form DEF 14A | |
05/10/2024
10:35 AM | Aptose Biosciences (Issuer)
LEDRU PHILIPPE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
